FDA clears GE's lung analysis software

The Food and Drug administration has cleared GE Healthcare's AdvantageALA, lung analysis software technology for CT used to evaluate lung nodules and other lesions.

Waukesha, WI-based GE said AdvantageALA also features a new digital contrast agent that will automatically highlight suspicious anatomical regions such as lung nodules.

By AuntMinnie.com staff writers
November 30, 2004

Related Reading

GE's RSNA advances include 64-slice PET/CT, HDMR, November 28, 2004

GE, Maquet in MR-guided surgery collaboration, November 24, 2004

GE notches Hawkeye mark, November 24, 2004

Road to RSNA, GE Healthcare, November 10, 2004

Copyright © 2004 AuntMinnie.com

Page 1 of 655
Next Page